Medical Director Affairs

Bruce Robinson, MD, PhD

** ********* **

Asheville, NC 28806

*********@***************.*** 609-***-****

QUALIFICATIONS

Excellent strategizing, research, and conceptualization for therapeutic market placement, launch,

and brand life story

Ability to relate and articulate effectively to clients and staff

In-depth therapeutic clinical sciences expertise in oncology, CNS, endocrinology, rare disease, C1, and more

CONSULTATION ROLES AGENCY AND MEDICAL AFFAIRS

AOR AND MEDICAL AFFAIRS • MEDICAL DIRECTOR

Boundless Life Sciences, Austin, TX • 2021 through PRESENT

Medical Director for Schedule 1 (C1) (lysergide d-tartrate; MindMed) FDA regulatory review processes for DSM-5 disorders GAD, MDD, AUD; stigma amelioration, commercialization, and HCP/public acceptance strategies; writer MOA/MOD videos

Assessment of clients’ (Biogen and TEVA) strategic marketing imperatives (Friedreich’s Ataxia and schizophrenia), advisor to therapeutic placement: marketing, tier, and affairs campaigns; medical affairs high-sciences formats, and creator of heuristic content; promotional reviewer

Develop company-wide educational platforms and lectures on new clients' therapeutics (MOA) and the associated disease states (MOD) for all education levels

CREATIVE DIRECTOR • COPY

W20 Creative • June 2019 through August 2019

Cimzia (psoriasis; UCB) Veeva platform re-skim and playbook development adding new indication, and revamp KPIs. Copy Director

CREATIVE DIRECTOR • COPY

MRM McCann Health • January 2018 through June 2019

Global HCP launch initiative Shingrix for US GSK (no.1 selling vaccine in 2018) and Relvar Ellipta for European markets. Strategic and content responsibilities to develop and align creative with didactic for multi-channel consistency, including print ads, direct mail, customized Veeva sales platform creation and development, website platform and associated drivers, banners, and more

AOR AND MEDICAL AFFAIRS • MEDICAL DIRECTOR

Array BioPharma, Boulder, CO • March 2018 through July 2018

Developed an innovative DTC patient education platform for Array’s first-ever product launch of an oncology PFS-extending therapeutic combo particular to specific patient types (Braftovi + Mektovi)

Collaborated with and guided Array’s Brand Teams (HCP and patient) for aligning strategic imperatives involving two marketing agencies (Cult and BioLumina) for patient-level education content

Constant regulatory content struggle with MLR and Brand Team’s and two agencies’ goals; resolved through creative content “word-smithing” for final Array upper-level approval. Connected numerous print and digital patient tools to the brand’s sciences and therapeutic benefits for an engaging and memorable brand story

Bruce Robinson, MD, PhD

AOR • MEDICAL DIRECTOR

2e Communications, St. Louis, MO • October 2016 through January 2018

Developed Medical Editorial Department and transitioned Creative and Account teams to support a fast-growing agency’s transformation to medical sciences and pharmaceutical clients (BEST SMALL AGENCY of the year 2 years back-to-back)

All medical sciences, client strategies, creative writing, and account responsibilities through me as final filter

Developed an internal review board to realign 2e’s project management structure. Organic outreach for account development through personal creation of POVs and client interaction, capturing CAR-T from Novartis, abemaciclib from Eli Lilly—over $4 million in new accounts

Day-to-day: in-house Foundry (internal think tank), hot deliverable fire suppression, new sciences review with teams (2e’s capabilities aligned with potential clients), and deliverable strategies

CAREER POSITIONS POST CLINICAL

VP • MEDICAL DIRECTOR

HCB Health, Austin, TX • August 2017 to 2019

Medical supervisory direction for onboarding HCB staff to clients’ therapeutics and targeted disease states, client-facing representation for pitches, strategic AOR direction for launches including rare diseases such as Alport Syndrome (Reata) in CKD, inherited retinal diseases and genetic testing treatment protocols for Spark Therapeutics, non-opioid analgesia in TKA and THA for Pacira (EXPAREL and iovera)

Developed all HCP marketing messaging for all brands, aligning messaging with label and marketing strategies. New Business Development point person (Arvelle, Acquestive, Y-mAbs, and more)

Developed company-wide educational platforms on new clients' therapeutics (MOA) and the associated disease states (MOD) for all education levels

MEDICAL DIRECTOR

Fingerpaint Marketing, Saratoga Springs, NY • • January 2013 to February 2014

Medical Marketing/Strategy Supervision for clients’ therapeutics, ensuring alignment to SOWs, strategizing market planning towards enriching client’s core values and product story, with onboarding the complexity of the molecule and disease states through innovative simplicity across the Fingerpaint community

Positioning for clients included Payer strategies, formulary placement, and optimum contractual pricing plans. $6.3 million in deliverables with six new launches, three FDA-designated Breakthrough Therapies

Resource for core marketing messaging and buy-in across client upper management to KPIs

Leveraged high-sciences to tactics based on the therapeutics’ Clinical Trials profiles to assist in language for the label and FDA regulatory review for marketing roll-out

Final filter on all copy from Copywriters and Creative towards alignment with brand story and functionality of deliverable; Mentor to junior writers

Developer medical content specific to brand or disease state when applicable to unbranded effort. Key participant through all medicolegal client reviews both in person and conferenced. Agency representative as “owner” and point person to the client with Account and Creative Teams.

MEDICAL DIRECTOR • COPY

Ignite Health, NYC, NY • April 2009 to January 2013

Writer, developer, “owner” scientific and creative content for DTP/DTC pharmaceutical marketing ventures in a variety of digital formats, including websites, mobile apps, e-detailing, MOAs, and banners

Bruce Robinson, MD, PhD

Specifics: decisive role developing Vertex’s INCIVEK Mobile App (DTP/hep C), reworked the Interactive Treatment Algorithm and Drug Interactions channels necessitating updates to the INCIVEK PI as well as the Treatment Management Guide.

Received commendation from Ignite Health (Vertex Board Product Team)

IA, UX development, and writer Istodax and Revlimid DTP websites (Celgene). Writer therapeutic overviews for team onboarding to new disease states and therapeutic competitors vs. opportunities, including the pertinent etiologies. Messaging and strategy contributor to team’s client’s products development, marketing position, and key deliverables optimizing KPIs and overall product market consistency

Numerous on-locale medico-legal reviews as author/writer. Pitch contributor as sciences expert

EDUCATION

Princeton University • AB, English

The University of South Carolina • BS, Molecular Biology

Medical University of South Carolina • MD/PhD • Howard Hughes Fellow

LANGUAGES

English and French

Contact this candidate